Specifications TableSubject area*Materials Science*More specific subject area*Biomaterials*Type of data*Tables and figures.*How data was acquired*Agilent 1200 nanopump (Reversed-phase (RP) nanoscale capillary liquid chromatography (nanoLC), Agilent Technologies Canada Inc., Ontario, Canada) connected to mass spectrometer 5600 with a nanoelectrospray ion source (ES-MS/MS, AB Sciex, MA, USA).*\
*LOGOS microwave hybrid tissue processor (Milestone, MI, USA).*\
*Leica microtome (Leica Biosystems Inc., ON, Canada).*\
*Zeiss Mirax Midi whole slide digital scanner (Carl Zeiss Canada Ltd, ON, Canada).*Data format*Raw and analyzed*Experimental factors***Mass spectrometry****: Eggshell membrane collected at the egg breaking unit was processed (washed, milled, sieved, and γ sterilized) into a micronized powder (\<100 μm), which was designated "Processed Eggshell Membrane Powder" (PEP). For proteomics, PEP samples were subjected to various extraction and solubilization strategies including moderate (via lithium dodecyl sulphate (LDS) and urea/ammonium bicarbonate (NH*~*4*~*HCO*~*3*~*)) and harsh conditions (via 3-mercaptopropionic acid (3-MPA) and NaOH/dimethylsulfoxide) conditions. Samples prepared by 3-MPA, NaOH/DMSO, and LDS/DTT treatment were subjected to in-gel digestion, while in the case of urea/NH*~*4*~*HCO*~*3*~*extraction, in-solution digestion was performed. The protein constituents of PEP were identified using LC/MS/MS analysis, with a false discovery rate (FDR) of 1% and at least two unique peptides. Keratins were discarded from the identified protein inventory. In addition, any protein identified with only one unique peptide (according to the Scaffold software interface) was discarded from the final protein inventory.*\
***Tissue processing****: The processed wound samples were cut into two halves (Upper and lower halves) and then embedded in paraffin (Leica Biosystems Inc., ON, Canada). PEP (50 mg) was suspended in PBS and centrifuged. The resultant pellet was centered in pre-embedding media and processed with the LOGOS tissue processor.*\
***Digital scanning:****Stained tissue and PEP sections were scanned with Zeiss Mirax Midi whole slide digital scanner (12 slides/scan and 40X objective lens). Exposure time was 10-100 ms (bright field) and the specimen threshold level of 40-45.*Experimental features*A complete protein inventory for PEP was created by merging the proteins identified by LC/MS/MS analysis after various extraction and solubilization strategies. Relative abundances of proteins identified in the PEP biomaterial were determined using Scaffold proteome software. The effect of PEP on wound healing was evaluated in the mouse excisional wound splinting model using the macroscopic planimetric timecourse (30--38 mice) and a histological scoring system (4 mice each at time points 3, 10, and 17). Various histological parameters related to wound healing were scored for all stained section. The absence of stainable collagen in the PEP biomaterial was confirmed using Masson\'s trichrome staining of the PEP pellet.*Data source location*MS/MS spectrometry was conducted in the Proteomics Platform Of Québec Genomics Center, CHU de Québec Research Center (Laval, QC, Canada).*\
*In vivo experiments were carried out in the animal care and veterinary service facility (ACVS), Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.*\
*Wound tissue sample processing, embedding, sectioning, staining, and scanning was performed in the Histology Core Facility, Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.*Data accessibility*The data are available within the article.*Related research article*Ahmed TAE, Suso HP, Maqbool A, and Hincke MT. Processed Eggshell Membrane Powder: Bioinspiration for an Innovative Wound Healing Product, Mater Sci Eng C Mater Biol Appl. 95 (2019) 192--203.***Value of the data**•The presented data describes the utilization of various extraction and solubilization strategies [@bib1], [@bib4] to identify the protein constituents of PEP by proteomics.•The proteomic approach allows the estimation of relative abundances of the main protein constituents of PEP biomaterial.•The data demonstrates the use of animals (C57BL/6J mice) for the planimetric timecourse and histological assessment of healing of the splinted excisional wound after application of a biomaterial (PEP).•The data describes an established histological scoring system used to assess the effect of PEP on various histological parameters critical to assess wound healing promotion.•The histological processing of PEP biomaterial via pelleting and pre-embedding in agar-formalin media provides researchers with a strategy to process powdered biomaterials and even cells.

1. Data {#sec1}
=======

The presented data demonstrates the utilization of various extraction strategies (moderate to harsh conditions) [@bib1], [@bib2], [@bib3], [@bib4] to identify the protein constituents of PEP using the proteomic approach ([Table 1](#tbl1){ref-type="table"}). A comprehensive PEP proteome was established and compared to the general ESM proteome ([Fig. 1](#fig1){ref-type="fig"} and [Table 2](#tbl2){ref-type="table"}). LC/MS/MS spectrometry data was interpreted in order to determine the relative abundance of the main protein constituents of PEP biomaterial ([Table 3](#tbl3){ref-type="table"}). The kinetics of wound healing (with and without PEP) in the mouse splinting excisional wound model was determined using a macroscopic planimetric strategy with histological scoring ([Table 4](#tbl4){ref-type="table"}). The histological scoring system was established to assess various histological parameters including degree of angiogenesis, collagen deposition, fibroblast infiltration, macrophage infiltration, polymorphonuclear cells (PMN) infiltration, fibrin clot formation, epidermal differentiation and indentation along with the presence of multinucleated giant cells ([Table 5](#tbl5){ref-type="table"}). Finally, PEP was stained with Masson\'s trichrome to confirm the absence of stainable collagen using an innovative pre-embedding histological approach ([Fig. 2](#fig2){ref-type="fig"}).Table 1Various extraction conditions used for the in-solution and in-gel digestion-based proteomic analysis of PEP.Table 1Extraction strategyIn-solution digestion[a](#tbl1fna){ref-type="table-fn"}In-gel digestionA[b](#tbl1fnb){ref-type="table-fn"}B[b](#tbl1fnb){ref-type="table-fn"}C[a](#tbl1fna){ref-type="table-fn"}Digestion buffer (urea 8 M/ammonium bicarbonate 100 mM), sonication (2 × 15s on -- 1min off on ice), centrifugation (16,000×g, 10min, 4 °C)3-mercaptopropionic acid (1.25 M), 1.7 M acetic acid, 24 hours, 80 °C, shaking water bath.NaOH (5% w/v), DMSO, 4 hours, 50 °C, hot plate stirrer.LDS (73mM)/DTT (50 mM), NuPAGE sample buffer only, 30 minutes, 70 °C, Heat block.[^1][^2]Fig. 1Venn chart showing a comparison of the PEP proteome to the recently published ESM proteome (Ahmed et al., 2017) [@bib4]. Twenty four (24) of the PEP proteins were not previously identified in the ESM proteome. Micronization to prepare PEP facilitated the identification of a greater number of proteins by increasing the efficiency of the in-solution digestion approach.Fig. 1Table 2Inventory of the PEP proteome, as compared to the ESM (hand-peeled and flakes) proteome.Table 2No.Protein nameGene SymbolGene IDPEPESM1Actin, γ1ACTG1415296YESYES2ADAM metallopeptidase with thrombospondin type 1 motif, 5ADAMTS5427971YESNO3A-kinase anchoring protein 12AKAP12421634NOYES4AlbuminALB396197YESYES5Aminopeptidase N, Alanyl (membrane) aminopeptidase.ANPEP395667NOYES6Angiopoietin like 3ANGPTL3100189558YESNO7Annexin A2ANXA2396297YESNO8Antigen identified by monoclonal antibody Ki-67MKI67423963NOYES9Apolipoprotein A-IAPOA1396536YESYES10Apolipoprotein BAPOB396535YESYES11Apolipoprotein DAPOD424893YESYES12Apolipoprotein H (β-2-glycoprotein I)APOH417431YESYES13Apovitellenin 1APOV1396476YESYES14ash1 (absent, small, or homeotic)-likeASH1L425064NOYES15ATPase H+ transporting accessory protein 2ATP6AP2418573YESNO16ATP-binding cassette, sub-family A (ABC1), member 4ABCA4424490NOYES17Avian β-defensin 9AvBD9414343NOYES18Avian β -defensin 10AvBD10414341NOYES19Avian β -defensin 11AvBD11414876YESYES20AvidinAVD396260YESYES21BPI fold containing family C, member BBPIFCB771461NOYES22Breast cancer 2BRCA2374139NOYES23Bromodomain containing 8BRD8416219NOYES24BTB domain containing 7BTBD7423424NOYES25Ca++-dependent secretion activator 2CADPS2417756NOYES26Cadherin 1, type 1, E-cadherin (epithelial)CDH1415860YESYES27Cadherin, EGF LAG seven-pass G-type receptor 3CELSR3107054381NOYES28Calcium channel, voltage-dependent, T type, a 1H subunitCACNA1H416526NOYES29Calcium/calmodulin-dependent protein kinase II βCAMK2B374174NOYES30Calmodulin 2CALM395855NOYES31Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6CHST6770257YESNO32Carboxypeptidase ECPE422424YESNO33Cathepsin BCTSB396329YESYES34Cathepsin E-A-likeCTSEAL417848YESNO35Cell division cycle 20BCDC20B426169NOYES36CentriolinCNTRL417121NOYES37Centrosomal protein 152kDaCEP152415437NOYES38Chondroitin sulphate proteoglycan 4CSPG4425524NOYES39Chromosome 1 open reading frame, human C12orf35C1H12ORF35418136NOYES40ClusterinCLU395722YESYES41Coagulation factor II (thrombin)F2395306NOYES42CochlinCOCH395779NOYES43Collagen III (α1 chain)COL3A1396340NOYES44Collagen IV (α 1 chain)COL4A1395530NOYES45Collagen IV (α 3 chain)COL4A3424797NOYES46Collagen IV (α 6 chain)COL4A6422350NOYES47Collagen V (α 2 chain)COL5A2423986NOYES48Collagen VII (α 1 chain)COL7A1427584NOYES49Collagen VIII (α 1 chain)COL8A1418378NOYES50Collagen X (α 1 chain)COL10A1100858979YESYES51Collagen XI (al chain)COL11A1374046NOYES52Collagen XII (al chain)COL12A1395875NOYES53Collagen XXII, (a l chain)COL22A1420315NOYES54Complement component 3C3396370YESNO55Contactin 5CNTN5395317NOYES56Cortactin binding protein 2CTTNBP2417766NOYES57Corticotropin releasing hormoneCRH404297NOYES58CREMP (cysteine rich ESM protein)CREMP776923YESYES59CREMP1N/AN/ANOYES60CREMP2N/AN/ANOYES61CREMP3N/AN/AYESYES62CREMP4N/AN/ANOYES63CREMP5N/AN/AYESYES64CREMP6N/AN/ANOYES65CTS telomere maintenance complex component 1CTC1418324NOYES66CUB and Sushi multiple domains 2CSMD2419640NOYES67Cystatin CCST3396497YESYES68Dedicator of cytokinesis 1DOCK1423960NOYES69Deleted in malignant brain tumors 1 protein-like (EW135).DMBT1L426826YESYES70DENN/MADD domain containing 4CDENND4C427236NOYES71DesmoplakinDSP420869NOYES72Dickkopf homolog 3DKK3396023YESYES73di-N-acetyl- chitobiaseCTBS424535NOYES74DnaJ heat shock protein family (Hsp40) member C7DNAJC7428312NOYES75Dynein, axonemal, heavy chain 1DNAH1415943NOYES76Dynein, axonemal, heavy chain 12DNAH12416004NOYES77Dynein, axonemal, heavy chain 9DNAH9417314NOYES78Dynein, cytoplasmic 2, heavy chain 1DYNC2H1418979NOYES79DystrophinDMD396236NOYES80EGF containing fibulin-like extracellular matrix protein 1EFEMP1428543NOYES81EGF-like repeats and discoidin I-like domains 3EDIL3427326YESYES82Enolase 2 (γ, neuronal)ENO2395689NOYES83Enolase 3ENO3396016NOYES84EPH receptor B3EPHB3396179NOYES85Eukaryotic translation elongation factor l alEEF1A1373963NOYES86Family with sequence similarity 20, member CFAM20C416445YESNO87Family with sequence similarity 21, member AFAM21A423772NOYES88F-box and WD repeat domain containing 8FBXW8417024NOYES89Fibrinogen γ chainFGG395837YESNO90Fibronectin 1FN1396133YESYES91flightless I homologFLII416515NOYES92Folate receptor 1 (adult)FOLR1395638NOYES93G protein-coupled receptor kinase interactor 1GIT1417584NOYES94G protein-coupled receptor kinase interactor 2GIT2374035NOYES95GalactosylceramidaseGLAC423394YESYES96Gastrokine 2GKN2419515YESYES97Glutamine and serine rich 1QSER1421599NOYES98Glutathione peroxidase 3GPX3427638YESYES99Glutathione S-transferase α 3GSTA3414896NOYES100Golgi glycoprotein 1GLG1396492YESNO101Group-specific component (vitamin D binding protein)GC395696NOYES102Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)HSPA5396487YESNO103Heat shock 70kDa protein 8HSPA8395853NOYES104Hemoglobin, α 1HBAA416652YESNO105Hemoglobin, γ GHBG2396485YESYES106HemopexinHPX419076YESYES107HEP21 proteinHEP21395192YESYES108Heterogeneous nuclear ribonucleoprotein A2/B1HNRNPA2B1420627NOYES109Heterogeneous nuclear ribonucleoprotein A3 homolog 1 -likeHNRNPA3100859627NOYES110Heterogeneous nuclear ribonucleoprotein D-likeHNRNPDL422601NOYES111Hexosaminidase B (β polypeptide)HEXB427204YESNO112Histone H1.11LHIST1H111L427892NOYES113Histone H1.11RHIST1H111R427896NOYES114Histone H2AHIST1H2A4404299NOYES115Histone H2BHIST1H2B8427886YESYES116Histone H3 family 3CH3F3C427887NOYES117Histone H4HIST1H47417950YESYES118Histone H5H1F0693250NOYES119Hyaluronan and proteoglycan link protein 3HAPLN3415495YESYES120Ig heavy chainN/AN/ANOYES121Ig heavy chain variable regionN/AN/ANOYES122Ig J polypeptide, linker protein for Ig a and α polypeptidesIGJ374117NOYES123Ig light chain variable regionN/AN/ANOYES124Ig mu chain C regionN/AN/AYESYES125Ig α heavy chainN/AN/AYESYES126Ig γchainN/AN/AYESYES127Ig λlight chainN/AN/ANOYES128Ig λ-like polypeptide 1IGLL1416928YESYES129Immunoglobulin like domain containing receptor 1ILDR1418358NOYES130Junction plakoglobinJUP429710NOYES131Kinesin family member 21BKIF21B421178NOYES132Kinesin family member 26AKIF26A423489NOYES133La ribonucleoprotein domain family, member 4BLARP4B420457NOYES134LDL receptor-related protein 11LRP11421629NOYES135Lectin, mannose-binding 2LMAN2100859676NOYES136Leucine zipper protein 1LUZP1428210NOYES137Lipocalin 8, extracellular fatty acid-binding proteinLCN396393YESYES138Lymphocyte antigen 86LY86420872YESYES139Lysozyme CLYZ396218YESYES140Lysyl oxidase-like 2LOXL2419533YESYES141Mediator complex subunit 15MED15416941NOYES142Melanoma inhibitory activity family, member 3MIA3421337NOYES143Milk fat globule-EGF factor 8 protein (lactadherin isoform 2)MFGE8415494YESYES144Mucin 6 oligomeric mucus/gel-forming (ovomucin, β subunint)MUC6414878YESYES145Mucin-5AC-likeLOC100859916100859916YESYES146Myeloid/lymphoid or mixed-lineage leukemia 2MLL2425846NOYES147Myeloid/lymphoid or mixed-lineage leukemia 3MLL3420437NOYES148Myosin, heavy chain 10, non-muscleMYH10396465NOYES149Myosin, heavy chain 9, non-muscleMYH9396469NOYES150N-acetylglucosamine-1-phosphate transferase, a and β subunitsGNPTAB418096NOYES151Neuron navigator 2NAV2422977NOYES152Neuron navigator 3NAV3417869NOYES153Neuropeptide YNPY396464NOYES154NeurotriminNTM395450NOYES155Nucleobindin 2NUCB2423071YESYES156Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEFOBSCN420395NOYES157Olfactomedin 4, tiarin-likeOLFM4418826YESYES158OvalbuminSERBIN14396058YESYES159Ovalbumin-related protein XSERPINB14C420898YESYES160Ovalbumin-related protein YSERPINB14B420897YESYES161Ovocalyxin 32 (Retinoic acid receptor responder 1)RARRES1395209YESYES162Ovocalyxin 36 (BPI fold containing family B, member 3)BPIFB3419289YESYES163Ovocleidin 116 (matrix extracellular phosphoglycoprotein)MEPE395256YESYES164Ovocleidin 17OC-17100313508YESYES165Ovoglobulin G2 (TENP)BPIFB7395882YESYES166Ovodefensin A1OvoDA1422030YESYES167Ovomucin, α subunitMUC5B395381YESYES168OvostatinOVST396151YESYES169Ovostatin-likeOVSTL425757NOYES170Ovotransferrin (transferrin)TF396241YESYES171p21 protein (Cdc42/Rac)-activated kinase 3PAK3422342NOYES172Phosphoglucomutase 5PGM5427215NOYES173Phospholipase B domain containing 1PLBD1417967YESNO174Piccolo (presynaptic cytomatrix protein)PCLO395319NOYES175PIT54 proteinPIT54395364YESYES176PleiotrophinPTN418125YESNO177Polycystic kidney and hepatic disease 1 (autosomal recessive)PKHD1422044NOYES178Polymeric immunoglobulin receptorPIGR419848NOYES179Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1PLOD1419485YESYES180Programmed cell death 6PDCD6420988NOYES181Prolyl 4-hydroxylase, β polypeptideP4HB374091YESNO182Prospero homeobox 1PROX1395802NOYES183Prostaglandin D2 synthase 21kDaPTGDS374110YESYES184Prostate stem cell antigenPSCA420302YESYES185Prostatic acid phosphatase-likeLOC428451428451YESYES186Protein O-fucosyltransferase 2POFUT2395112YESNO187Protein phosphatase, Mg2+/Mn2+ dependent, 1JPPM1J419873NOYES188Protein tyrosine phosphatase, receptor type, APTPRA396060NOYES189Protocadherin 1PCDH1416194NOYES190Quiescin Q6 sulfhydryl oxidase 1QSOX1373914YESYES191Retbindin (Riboflavin-binding protein)RTBDN396449YESYES192Retinoic acid receptor responder 2RARRES2420366YESYES193Rho guanine nucleotide exchange factor (GEF) 17ARHGEF17777518NOYES194Ribosomal protein L36RPL36373936NOYES195Ring finger protein 17RNF17418961NOYES196Rootletin, ciliary rootlet coiled-coilCROCC428191NOYES197RPE-spondin-likeLOC771089771089NOYES198Salivary amylase, αlAAMY1A414139NOYES199Sal-like 4SALL4769286NOYES200Secretoglobin family 1C member 1 -likeLOC101749303101749303NOYES201Secretory trypsin inhibitorSPINK1101749216NOYES202Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3GSEMA3G415945YESYES203Serine peptidase inhibitor, Kazal type 2 (acrosin-trypsin inhibitor)SPINK2770729YESYES204Serine peptidase inhibitor, Kazal type 5, (Ovoinhibitor)SPINK5416235YESYES205Serine peptidase inhibitor, Kazal type 7 (ovomucoid)SPINK7416236YESYES206Serine/threonine kinase 38STK38428260NOYES207Serpin peptidase inhibitor, clade B (ovalbumin), member 1SERPINB1420894NOYES208Serpin peptidase inhibitor, clade B (ovalbumin), member 5SERPINB5420900NOYES209Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2SERPINE2424805YESYES210Serpin peptidase inhibitor, clade F (α-2 antiplasmin, pigment epithelium derived factor), member 2SERPINF2100857105YESYES211Shroom family member 3SHROOM3422636NOYES212Similar to arf-GAP with Rho-GAP domain of ZebrafishN/AN/ANOYES213Similar to CREB binding protein b of ZebrafishN/AN/ANOYES214Similar to cadherin 4 of ZebrafishCDH4N/ANOYES215Similar to Calumenin A of ZebrafishN/AN/AYESYES216Similar to IgGFc-binding protein-like of wild turkey.ZANN/ANOYES217Similar to Kunitz-like protease inhibitorLOC771972771972YESYES218Similar to metastasis associated 1 of ZebrafishMTA1N/ANOYES219Similar to Septin 4a of ZebrafishN/AN/ANOYES220Similar to transcription factor EB ZebrafishTFEBN/ANOYES221Similar to zinc finger ZZ-type and EF-hand domain-containing protein 1 of wild turkeyZZEF1100541118NOYES222Spectrin repeat containing, nuclear envelope 1SYNE1421640YESYES223Spectrin, β, non-erythrocytic 5SPTBN5423225NOYES224Sperm associated antigen 16SPAG16424009NOYES225Stromal cell derived factorSDF4419423YESYES226Syndecan binding protein (syntenin)SDCBP421136YESNO227TATA box binding protein likeTBPL2776269NOYES228Tenascin CTNC396440YESYES229Teneurin transmembrane protein 3TENM3422557NOYES230Tetratricopeptide repeat domain 3TTC3418518NOYES231Thyroid hormone receptor interactor 11TRIP11423414NOYES232TIMP metallopeptidase inhibitor 3TIMP3396483YESYES233TitinTTN424126NOYES234transcobalamin 2TCN2429737YESNO235Transient receptor potential cation channel, subfamily M, member 1TRPM1427494NOYES236Transient receptor potential cation channel, subfamily V, member 2TRPV2417603NOYES237Transthyretin.TTR396277YESYES238Tsukushi, small leucine rich proteoglycanTSKU419088YESYES239Tumor necrosis factor receptor superfamily, member 6b, decoyTNFRSF6B395096YESYES240Tumor necrosis factor superfamily member 10TNFSF10378894YESNO241Ubiquitin BUBB396190NOYES242Ubiquitin specific peptidase 4 (proto-oncogene)USP4415937NOYES243Ubiquitin-protein ligase E3BUBE3B776286NOYES244Uncharacterized LOC107049386LOC107049386107049386NOYES245Uncharacterized LOC771994LOC771994771994YESNO246Uncharacterized protein (R4GJG8)N/AN/ANOYES247Uncharacterized protein (UPI0000448E55)N/AN/AYESNO248Uncharacterized protein (UPI0000E802A1)N/AN/AYESNO249Uncharacterized protein (UPI000240B987)N/AN/ANOYES250Uncharacterized proteins (R4GIK1)N/AN/ANOYES251Uridine-cytidine kinase 1 -like 1UCKL1419255NOYES252Vacuolar protein sorting 13 homolog DVPS13D419481NOYES253Vitelline membrane outer layer protein 1VMO1418974YESYES254Vitellogenin 1VTG1424547YESYES255Vitellogenin 2VTG2424533YESYES256VitronectinVTN395935YESYES257v-raf murine sarcoma viral oncogene homolog BBRAF396239NOYES258WAP four-disulfide core domain 8WFDC8419301YESYES259WSC domain containing 2WSCD2416887NOYES260YLP motif containing 1; (C14orf170)YLPM1423356NOYES261Zinc finger protein 185-likeLOC422301422301NOYES262Zinc finger protein 335ZNF335396131NOYES263Zinc finger, CCHC domain containing 11ZCCHC11424642NOYES264Zona pellucida glycoprotein 1 (sperm receptor)ZP1395418NOYES265Zona pellucida sperm-binding protein 3ZP3378906NOYES266A thalassemia/mental retardation syndrome X-linkedATRX422331NOYES267α1 acid glycoproteinORM1395220YESYES268α2 macroglobulin-like 1A2ML1418254YESYES269α2 macroglobulin-like 4A2ML4100858010NOYES270β 1,4-N-acetyl-galactosaminyl transferase 4B4GALNT4770601NOYES271β microseminoprotein-likeLOC101750704101750704YESYES272β2 microglobulinB2M414830NOYESTotal110248Table 3Relative abundance of the main proteins constituting the PEP biomaterial. Data is arranged according to the percent abundance.Table 3Gene symbolAverage total spectral count% abundanceLOXL233.328.0CREMPs31.227.0LYZ13.812.0COL10A111.510.0SERBIN147.36.0MEPE4.03.0TF3.03.0CLU2.02.0HAPLN32.02.0OC-172.52.0GKN21.00.8NUCB21.00.8ORM11.00.8QSOX11.00.8SERPINB14B1.00.8SERPINB14C1.00.8VTG21.00.8Table 4Number of mice used for the *in vivo* study.Table 4Purpose of the studyNumber of C57BL/6J mice evaluatedDay 0Day 3Day 7Day 10Day 14Day 17Wound closure curve383834343030Histology040404Total383834343030Table 5Scoring scheme for the different histological parameters to assess wound healing.Table 5Histological parameterScore012345AngiogenesisAbsentScantyLowModerateMarkedProfoundCollagen depositionAbsentScanty/disorganizedlow/fragmentedModerate/separatedProfound/organizedRestoredFibroblast infiltrationAbsentScantyLowModerateMarkedProfoundMacrophage infiltrationAbsentScantyLowModerateMarkedProfoundPMN infiltrationAbsentScantyLowModerateMarkedProfoundFibrin clotAbsentScantyLowModerateMarkedProfoundEpidermal differentiation and indentationAbsentScantyLowModerateMarkedProfoundMultinuclear giant cellsAbsentScantyLowModerateMarkedProfoundFig. 2Masson\'s trichrome staining showing the amorphous nature of PEP biomaterial and the absence of stainable collagen fibres.Fig. 2

2. Experimental design, materials, and methods {#sec2}
==============================================

2.1. Proteomic analysis {#sec2.1}
-----------------------

Processed eggshell membrane powder (PEP, \<100 μm) [@bib3] was subjected to various extraction and solubilization strategies as utilized previously for ESM proteomics [@bib4]([Table 1](#tbl1){ref-type="table"}). A complete protein inventory for PEP was created by merging the proteins identified after application of moderate extraction \[lithium dodecyl sulphate/dithiothreitol (LDS/DTT) or urea/ammonium bicarbonate (NH~4~HCO3)\] and harsh solubilization conditions \[3-mercaptopropionic acid (3-MPA) or sodium hydroxide/dimethylsulfoxide (NaOH/DMSO)\] ([Fig. 1](#fig1){ref-type="fig"} and [Table 2](#tbl2){ref-type="table"}). Conditions of in-gel (3-MPA, NaOH/DMSO, and LDS/DTT) or in-solution \[urea/NH~4~HCO3\] tryptic digestion were applied and the resultant peptides were analyzed using the 5600 mass spectrometer with a nanoelectrospray ion source connected to Agilent 1200 nanopump (ES-MS/MS) [@bib3], [@bib4].

2.2. Relative abundance of PEP protein constituents {#sec2.2}
---------------------------------------------------

MS/MS peak lists were generated using ProteinPilot (Version 4.5) and analyzed using Mascot (Version 2.4.0) and X!Tandem (CYCLONE version), both programmed to search the TAX_GallusGallus_9031_20141114 database (unknown version, 222,250 entries). Validation of MS/MS based peptide and protein identification was performed using Scaffold Proteome software (version 4.3.4). MS/MS spectra were searched against the Uniprot and NCBI chicken databases. The relative abundance of the PEP protein constituents was estimated by averaging the total spectral count of each identified protein using the aforementioned Scaffold Proteome software ([Table 3](#tbl3){ref-type="table"}).

2.3. In vivo study {#sec2.3}
------------------

All in vivo experiments were conducted following the approved animal protocol (CMM 2108) by the University of Ottawa Animal Care committee and according to the guidelines of the Canadian Council on Animal Care (CCAC). All animal protocols are in compliance with the NIH Guide for Care and Use of Laboratory Animals (Animal Welfare Assurance \# A5043-01). Capacity of PEP for promotion of wound healing was assessed using the well-established mouse excisional wound splinting model [@bib5]and the subsequent macroscopic planimetric timecourse [@bib6] and histological scoring. A total of 38C57BL/6J male mice (10--12 weeks old, Jackson Laboratories, USA) were used for the entire study ([Table 4](#tbl4){ref-type="table"}).

2.4. Histological assessments {#sec2.4}
-----------------------------

PEP (50 mg) was suspended in 1 mL PBS and centrifuged for 5 minutes at 13,000 rpm. The resultant pellet was centered in a base mould; pre-mounting media composed of 2% agar and 10% formalin was poured gently over the pellet and left for few minutes to solidify. The resulted PEP block was processed using the LOGOS tissue processer, embedded in paraffin and then sectioned using a Leica microtome. PEP sections were stained using Masson trichrome to confirm the absence of stainable collagen in the PEP biomaterial ([Fig. 2](#fig2){ref-type="fig"}). For evaluation of wound healing, histological scoring system was established to assess parameters that represent wound healing [@bib7], [@bib8], [@bib9], including degree of angiogenesis, collagen deposition, fibroblast infiltration, macrophage infiltration, polymorphonuclear cells (PMN) infiltration, fibrin clot formation, epidermal differentiation and indentation along with presence of multinucleated giant cells. Every parameter was given a score of 0--5 based on its graded level of abundance. Score 0 indicates complete absence, while score 5 indicates profound manifestation of the assessed parameter. Scoring of collagen deposition was based, not only on the degree of abundance (i.e. absent, scanty, low, moderate, profound, restored), but also on the degree of organization (disorganized, fragmented, separated, organized) ([Table 5](#tbl5){ref-type="table"}).
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[^1]: Moderate extraction conditions.

[^2]: Harsh solubilization conditions.
